The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Molecular Diagnostics For Sexually Transmitted Diseases Market During 2026–2030?
The molecular diagnostics for sexually transmitted diseases market size has experienced rapid expansion in recent years. It is forecast to increase from $3.67 billion in 2025 to $4.07 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.7%. This historical growth can be attributed to several factors, including a reliance on conventional serological tests, the limited availability of automated PCR systems, low awareness of molecular diagnostics in emerging markets, the growing prevalence of sexually transmitted infections, and a manual, labor-intensive testing workflow.
The molecular diagnostics for sexually transmitted diseases market is anticipated to experience rapid expansion in the next few years, projected to reach $6.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period is fueled by technological progress in automated PCR and nucleic acid extraction, the wider availability of point-of-care molecular diagnostics, improvements in healthcare infrastructure in developing regions, increased adoption of laboratory information management systems (LIMS), and growing investment in research and development for rapid and multiplexed diagnostic assays. Significant trends expected during this period include the increasing use of nucleic acid-based testing methods, the expansion of point-of-care molecular diagnostic solutions, a rising demand for prompt and accurate STD detection, the integration of molecular diagnostics with laboratory information systems, and advancements in automated PCR and high-throughput diagnostic platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp
Which Strategic Drivers Are Supporting The Molecular Diagnostics For Sexually Transmitted Diseases Market Development?
An increasing prevalence of sexually transmitted infections is projected to stimulate the growth of the molecular diagnostics for sexually transmitted diseases market moving forward. Sexually transmitted infections (STIs) are illnesses caused by bacteria, viruses, or parasites transferred through sexual contact, affecting the reproductive and urinary systems. The rising occurrence of sexually transmitted infections primarily stems from the inconsistent use of protection methods. This lack of protection allows for easier transmission of infections among sexually active individuals. Molecular diagnostics for sexually transmitted infections (STIs) are crucial in managing these infections by enabling early and accurate detection of pathogens, even in asymptomatic individuals, thereby facilitating timely treatment, reducing disease transmission, and improving overall patient outcomes. For instance, in June 2024, according to the UK Health Security Agency (UKHSA), a UK-based government agency, in 2023, there were 401,800 new STI diagnoses in England, marking a 4.7% increase compared to the 383,789 cases reported in 2022. Consequently, a rising prevalence of sexually transmitted infections is driving the growth of the molecular diagnostics for sexually transmitted diseases market.
What Segment Types Are Included In The Molecular Diagnostics For Sexually Transmitted Diseases Market Analysis?
The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented –
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Laboratory Testing, Point-Of-Care Testing
3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications
Subsegments:
1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software
Which Trends Are Shaping The Molecular Diagnostics For Sexually Transmitted Diseases Market Landscape?
Major companies active in the molecular diagnostics for sexually transmitted diseases market are concentrating on developing groundbreaking solutions, particularly rapid point-of-care polymerase chain reaction (PCR) devices, to boost diagnostic speed, accuracy, and accessibility. These rapid point-of-care PCR devices are portable molecular diagnostic instruments that integrate sample preparation, amplification, and detection into one compact unit, allowing for timely and highly sensitive pathogen identification outside traditional laboratory environments. For instance, in March 2025, Visby Medical, a US-based diagnostic technology firm, launched the Visby Medical Women’s Sexual Health Test. This product is a single-use, handheld PCR device crafted to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples in 30 minutes. It functions independently, requiring no external instrumentation or cold-chain logistics, features an embedded amplification system, and delivers lab-quality outcomes directly at the point of care to support swift clinical decisions. Authorized for prescription home use, it marks the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) applicable outside clinical settings. This launch underscores a move toward decentralized diagnostic options that enhance accessibility, especially for underserved or remote populations.
Which Companies Are Engaged In The Molecular Diagnostics For Sexually Transmitted Diseases Market Environment?
Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.
Access The Complete Molecular Diagnostics For Sexually Transmitted Diseases Market Report:
Which Region Stands As The Largest Contributor To The Molecular Diagnostics For Sexually Transmitted Diseases Market?
North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Molecular Diagnostics For Sexually Transmitted Diseases Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Molecular Diagnostics For Sexually Transmitted Diseases Market 2026, By The Business Research Company
Trade Credit Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/trade-credit-insurance-global-market-report
Household Insecticides Market Report 2026
https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report
Household Lending Market Report 2026
https://www.thebusinessresearchcompany.com/report/household-lending-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model